Skip to main content
. 2018 Feb 14;9(2):233. doi: 10.1038/s41419-018-0275-9

Fig. 2. FOXD2-AS1 promotes proliferation and migration/invasion of bladder cancer cells.

Fig. 2

a Expression alteration of FOXD2-AS1 was shown in FOXD2-AS1 overexpression bladder cancer cells. b qRT-PCR was used to evaluate expression of FOXD2-AS1 in two independent siRNAs transfected bladder cancer cells. The figures in A and B showed representative results of three independent experiments. c and d MTT assays were performed to determine the T24 and UM-UC-3 cell growth capacities after silencing of FOXD2-AS1 via specific siRNAs transfections. The representative figure of three independent experiments showed that FOXD2-AS1 obviously promoted bladder cancer cell growth. *p < 0.05, **p < 0.01. e FOXD2-AS1 increased colony formation of bladder cancer cells. Left: representative figure of colony formation assays. Right: Error bars represent the mean ± S.D. from three independent experiments. *p < 0.05, **p < 0.01. f The representative figure of EdU assays demonstrated that knockdown of FOXD2-AS1 decreased the number of cells in the S phase. Error bars represent the mean ± S.D. from three independent experiments. *p < 0.05, **p < 0.01. g and h Cell migration distances and invasiveness were also (b) positively associated with FOXD2-AS1 expression in T24 and UM-UC-3 cells. Error bars represent the mean ± S.D. from three independent experiments. *p < 0.05, **p < 0.01